T. Ishida et al., A NOVEL PLASMA FACTOR INITIATING COMPLEMENT ACTIVATION ON CETYLMANNOSIDE-MODIFIED LIPOSOMES IN HUMAN PLASMA, International journal of pharmaceutics, 164(1-2), 1998, pp. 91-102
The possibility that the human complement (C) system plays a critical
role in both destabilization and opsonization of the liposomes modifie
d with cetylmannoside (Man-MLVs) was demonstrated in our previous in v
itro study. In this study, our attention was focused on the underlying
mechanism of activation of the C system by the Man-MLVs. It was found
that the Man-MLVs had significant ability to activate the C system an
d the activation proceeded through the Clq-dependent classical pathway
. Pretreatment of human plasma with Man-MLVs at low temperature (4 deg
rees C) diminished the ability of the C system to destabilize the homo
logous liposomes without affecting the ability to lyse rabbit erythroc
ytes. However, the C-dependent destabilization did not disappear by th
e pretreatment with PC-MLVs. The results suggest that a plasma factor,
which specifically adsorbs to Man-MLVs but not PC-MLVs, is essential
for initiating the C activation. The plasma factor was obviously disti
nguished from any known classical C pathway (CCP) activators, since th
e adsorption of the plasma factor to Man-MLVs was not inhibited by tre
atment with EGTA/Mg2+, soluble sugars (GlcNAc, ManNAc or D-mannose) or
Con-A Sepharose. In addition, isolation of the plasma factor was atte
mpted by the following procedure: PEG precipitation, DEAE Sepharose ch
romatography and gel filtration chromatography. In a series of these i
solations, the plasma factor was found to be a protein with higher mol
ecular weight at least than 669000 Da. It was concluded that the activ
ation of the human C system by the Man-MLVs proceeded through the CCP
in the presence of a novel plasma factor. (C) 1998 Elsevier Science B.
V. All rights reserved.